U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Substance Class Protein
Created
by admin
on Mon Mar 31 21:46:43 GMT 2025
Edited
by admin
on Mon Mar 31 21:46:43 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG2/4
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
4971UQC7F3
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
OLENDALIZUMAB
INN   USAN  
INN   USAN  
Official Name English
LENDALIZUMAB
WHO-DD  
INN  
Preferred Name English
ALXN1007
Code English
OLENDALIZUMAB [USAN]
Common Name English
IMMUNOGLOBULIN, ANTI-(HUMAN COMPLEMENT C5A) (HUMAN-MUS MUSCULUS ALXN1007 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS ALXN1007 .KAPPA.-CHAIN, DIMER
Common Name English
ALXN-1007
Code English
olendalizumab [INN]
Common Name English
Olendalizumab [WHO-DD]
Common Name English
Code System Code Type Description
DRUG BANK
DB14834
Created by admin on Mon Mar 31 21:46:43 GMT 2025 , Edited by admin on Mon Mar 31 21:46:43 GMT 2025
PRIMARY
INN
10037
Created by admin on Mon Mar 31 21:46:43 GMT 2025 , Edited by admin on Mon Mar 31 21:46:43 GMT 2025
PRIMARY
NCI_THESAURUS
C118441
Created by admin on Mon Mar 31 21:46:43 GMT 2025 , Edited by admin on Mon Mar 31 21:46:43 GMT 2025
PRIMARY
SMS_ID
300000021888
Created by admin on Mon Mar 31 21:46:43 GMT 2025 , Edited by admin on Mon Mar 31 21:46:43 GMT 2025
PRIMARY
CAS
1337966-73-0
Created by admin on Mon Mar 31 21:46:43 GMT 2025 , Edited by admin on Mon Mar 31 21:46:43 GMT 2025
PRIMARY
USAN
ZZ-107
Created by admin on Mon Mar 31 21:46:43 GMT 2025 , Edited by admin on Mon Mar 31 21:46:43 GMT 2025
PRIMARY
FDA UNII
4971UQC7F3
Created by admin on Mon Mar 31 21:46:43 GMT 2025 , Edited by admin on Mon Mar 31 21:46:43 GMT 2025
PRIMARY
From To
1_22 1_96
1_147 1_203
1_260 1_320
1_366 1_424
2_22 2_96
2_147 2_203
2_260 2_320
2_366 2_424
1_134 3_218
2_134 4_218
1_222 2_222
1_223 2_223
1_226 2_226
1_229 2_229
3_23 3_92
3_138 3_198
4_23 4_92
4_138 4_198
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_296
N 2_296
Related Record Type Details
COMPLEMENT C5 ALPHA CHAIN
TARGET -> INHIBITOR
Related Record Type Details
OLENDALIZUMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966